Songjiang Ma sold $41k of GYRE
President at GYRE THERAPEUTICS, INC.. 4,000 shares at an average of $10.19, traded Mar 7, 2025, filed Mar 11, 2025.
Score components
- +20RolePresident
- +6Trade size$41k at market
- 0Share of holdings soldSold 0.1% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -35.8%, 3m -20.7%, 6m -32.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-008091, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 7, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -53 | $13.03 | $691 | 2,843,207 | Mar 11, 2025 |
| Mar 7, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -41 | $12.14 | $498 | 2,843,166 | Mar 11, 2025 |
| Mar 7, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,906 | $10.13 | $19k | 2,841,260 | Mar 11, 2025 |
| Mar 10, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -2,000 | $10.14 | $20k | 2,839,260 | Mar 11, 2025 |
Related signals
Other insiders at GYRE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $69k 11,000 shares | -2% | |
| 5Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $17k 2,800 shares | -0% | |
| 16Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $129k 20,918 shares | -3% | |
| 17Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $219k 34,976 shares | -5% | |
| 11Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $46k 7,500 shares | -1% | |
| 16Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $137k 22,220 shares | -3% | |
| 20Weak | GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $59k 9,320 shares | -1% | |
| 25Weak | GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $195k 28,680 shares | -4% | |
| 22Weak | GYRE THERAPEUTICS, INC. | Ying Luo Chief Executive Officer | $83k 10,315 shares | -0% | |
| 5Weak | GYRE THERAPEUTICS, INC. | Songjiang Ma President | $26k 2,558 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.